How to leverage novel trial designs and real-world data to support a cancer drug submission with an evidence strategy that is both approvable and reimbursable.
Alex Gee, Senior Director, Pricing & Market Access Parexel
Advertisement
Articles by Alex Gee, Senior Director, Pricing & Market Access Parexel
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
2
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
3
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5